With the rising prevalence and severity of substance use disorders, effective treatment and patient care are critical. This presentation provides guidance on identifying substance use disorders, managing withdrawal across various substances, and recognizing potential complications. It also highlights monitoring practices and assessment tools, such as the Clinical Institute Withdrawal Assessment, to evaluate severity and guide treatment strategies. The session offers key considerations for developing appropriate pharmacological interventions.
Management of the following substances are covered in this session:
- Alcohol
- Benzodiazepines
- Cocaine
- Marijuana
- Methamphetamines
- Nicotine
- Opioids
Sample